Insider Transactions in Q3 2023 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.4%
|
$15,000
$15.0 P/Share
|
|
Sep 06
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
950
-0.94%
|
$12,350
$13.74 P/Share
|
|
Sep 06
2023
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
972
-0.99%
|
$12,636
$13.72 P/Share
|
|
Sep 06
2023
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
892
-1.09%
|
$11,596
$13.73 P/Share
|
|
Sep 05
2023
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-0.27%
|
$6,286
$14.46 P/Share
|
|
Sep 05
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
426
-0.84%
|
$5,964
$14.46 P/Share
|
|
Sep 05
2023
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,440
-0.57%
|
$20,160
$14.46 P/Share
|
|
Sep 05
2023
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
436
-0.88%
|
$6,104
$14.46 P/Share
|
|
Sep 05
2023
|
Nerissa Kreher Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-0.97%
|
$5,614
$14.46 P/Share
|
|
Sep 01
2023
|
Natarajan Sethuraman President, Research & Develop. |
BUY
Grant, award, or other acquisition
|
Direct |
14,200
+7.81%
|
-
|
|
Sep 01
2023
|
Kory James Wentworth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,200
+21.8%
|
-
|
|
Sep 01
2023
|
Dipal Doshi CEO |
BUY
Grant, award, or other acquisition
|
Direct |
49,650
+16.53%
|
-
|
|
Sep 01
2023
|
Nathan J Dowden President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
14,200
+22.27%
|
-
|
|
Sep 01
2023
|
Nerissa Kreher Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,200
+25.57%
|
-
|
|
Aug 14
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.49%
|
$15,000
$15.67 P/Share
|
|
Aug 04
2023
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,898
-20.27%
|
$96,572
$14.14 P/Share
|
|
Aug 04
2023
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,898
+16.85%
|
$13,796
$2.1 P/Share
|
|
Aug 03
2023
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,464
-25.86%
|
$132,496
$14.74 P/Share
|
|
Aug 03
2023
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,464
+20.55%
|
$18,928
$2.1 P/Share
|
|
Aug 02
2023
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,348
-9.52%
|
$155,220
$15.97 P/Share
|
|
Aug 02
2023
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,348
+21.64%
|
$20,696
$2.1 P/Share
|
|
Jul 11
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,884
-9.56%
|
$69,912
$18.0 P/Share
|
|
Jul 11
2023
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,884
+8.73%
|
$7,768
$2.1 P/Share
|
|
Jul 11
2023
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
14,852
-8.82%
|
$267,336
$18.04 P/Share
|
|
Jul 11
2023
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
3,897
-9.92%
|
$70,146
$18.05 P/Share
|
|
Jul 10
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,116
-14.27%
|
$103,972
$17.98 P/Share
|
|
Jul 10
2023
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,116
+12.49%
|
$12,232
$2.1 P/Share
|
|
Jul 10
2023
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
3,026
-1.77%
|
$54,468
$18.0 P/Share
|
|
Jul 10
2023
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
3,200
-7.53%
|
$57,600
$18.0 P/Share
|